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Abstract: The emetic syndrome of Bacillus cereus is a food intoxication caused by cereulide (CER)
and manifested by emesis, nausea and in most severe cases with liver failure. While acute effects
have been studied in the aftermath of food intoxication, an exposure to low doses of cereulide might
cause unnoticed damages to the intestines and liver. The toxicity which relies on the mitochondrial
dysfunction was assessed on Caco-2 and HepG2 cells after exposure of one, three and ten days
to a range of low doses of cereulide. Oxygen consumption rate analyses were used to study the
impact of low doses of CER on the bioenergetics functions of undifferentiated Caco-2 and HepG2
cells using Seahorse XF extracellular flux analyzer. Both Caco-2 and HepG2 cells experienced
measurable mitochondrial impairment after prolonged exposure of 10 days to 0.25 nM of cereulide.
Observed mitochondrial dysfunction was greatly reflected in reduction of maximal cell respiration.
At 0.50 nM CER, mitochondrial respiration was almost completely shut down, especially in HepG2
cells. These results corresponded with a severe reduction in the amount of cells and an altered
morphology, observed by microscopic examination of the cells. Accurate and robust quantification of
basal respiration, ATP production, proton leak, maximal respiration, spare respiratory capacity, and
non-mitochondrial respiration allowed better understanding of the effects of cereulide in underlying
respiratory malfunctions in low-dose exposure.
Keywords: cereulide; emetic toxin; Bacillus cereus; Seahorse XF; extracellular flux; mitochondrial
dysfunction; respiration; oxygen consumption rate; depsipeptides
Key Contribution: The highly sensitive Seahorse XF analysis of oxygen consumption rate show
modulated mitochondrial respiration in Caco-2 and HepG2 cells caused by very low doses
of cereulide.
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1. Introduction
Cereulide (CER) is a toxin notorious for being the causative agent of an acute Bacillus cereus emetic
food intoxication [1–3]. This emetic syndrome, characterized by nausea, vomiting and malaise 0.5–5 h
after ingestion of food containing cereulide, is usually mild and self-limiting. However, in some cases
the food poisoning leads to severe clinical pathologies including liver failure with rhabdomyolysis [4],
or liver failure with acute encephalopathy and a dysfunction of the beta-oxidation process [5].
CER is a cyclic and lipophilic dodecadepsipeptide (1.2 kDa) that acts as a potassium ionophore
on the mitochondrial membrane and is structurally related to a known antibiotic valinomycin [6].
Both cereulide and valinomycin are known K+ ion-selective ionophores. Cereulide and valinomycin
have 12 stereogenic centers containing very similar sequence of cyclo [-D-O-Leu-D-Ala-L-O-Ala-L-Val-]3
in cereulide and cyclo [-D-O-Val-D-Val-L-O-Ala-L-Val-]3 in valinomycin. As K+ ion-selective ionophores
both cereulide and valinomycin cause a potassium-dependent drop in the transmembrane potential of
mitochondria. As such, both compounds may affect mitochondrial function. Some differences in their
biological activity may be explained by differences in their chemical properties, including differences
in amino acid composition. Cereulide is reported to exibit the K+-ion-selective ionophore property at a
lower concentration than valinomycin [7].
As with valinomycin [8–11], cereulide is produced through a unique nonribosomal peptide
biosynthesis [12,13]. It is formed in food during late exponential and stationary growth phases of
B. cereus growth [14] and is highly resistant towards heat (80 min at 121 ◦C and 60 min at 150 ◦C at
pH 9.5; no inactivation at 121 ◦C and 150 ◦C at pH of 9 and below [15]), pH (pH range from 2 to 11),
and proteolytic enzymes such as pepsin and trypsin [15,16]. As a consequence, food processing and
preparation or reheating of cooked foods prior to consumption will not destroy CER, and the intact
toxin will pass the stomach and reach the intestines without the loss of its activity. Most of the reported
cases were related to food leftovers or takeaway pasta and rice dishes that were improperly stored,
allowing the growth of B. cereus with production of CER [1,17]. Reported studies generally focused on
starch-rich foods (mainly rice and pasta) linked with foodborne outbreaks, while the prevalence of CER
in other food categories is somewhat less described [18]. The acute intoxication dose provoking clinical
emetic manifestations was estimated at ca. 8–10 µg CER per kg of body weight [19–21]. Prevalence data
on CER in food samples not related to foodborne outbreaks are less reported and generally indicate
low CER concentration in tested samples [22,23]. A Belgian study conducted on rice dishes collected
in Chinese-style restaurants revealed that CER was found in 7.4% of the samples, with an average CER
concentration of 4 µg·kg−1 food [17]. This concentration is much lower compared to the levels found
in foods incriminated in foodborne outbreaks, such as for example 1 µg/g to 10 µg/g as reported for
an outbreak in a kindergarten in Norway [24]. Besides the acute effects associated with food poisoning,
a repeated exposure to sub-emetic doses (doses that do not cause visible emetic symptoms and thus
result in an un-noticed exposure) of CER present in food from restaurants or households that was
improperly stored might be potently harmful [25–27].
Although B. cereus is ubiquitously distributed in the environment, it is known that only emetic
strains of B. cereus that possess the ces gene have the potential to produce CER [28]. Messelhausser et
al. investigated the prevalence of emetic strains in foods of different origin (n = 3654) and reported
that about 1% of tested samples contain the emetic strain [29]. However, the emetic strains were not
only detected in the expected farinaceous foods but also in vegetables, fruit products, sauces, soups,
and salads and in cheese and meat products. Although the prevalence was very low, a relatively
higher incidence of emetic B. cereus strains was found in tested ice cream samples (4.7%) [30]. A study
conducted on different foods on the Dutch market revealed that even 16.8% of the tested isolates
produced CER and/or contained the ces gene [23]. In clinical stool samples analyzed in South
Korea, 20% of B. cereus isolates harbored ces genes in comparison to ca. 34–87% harboring (some of)
enterotoxins genes. Relatively lower prevalence of cer + B. cereus and the fact that CER is not produced
at refrigeration temperatures (tmin for CER is considered to be 10–12 ◦C) contribute to the relatively
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low prevalence of CER in food. In addition, amounts of CER produced at 12◦ (are much smaller than
at 30–37 ◦C (2–8 µg/g in bacterial wet weight and 31–194 µg/g bacterial wet weight, respectively) [31].
Since CER causes gastroenteritis symptoms and the human exposure is predominantly via food,
the gut is the first place in the human body exposed to the toxin. In view of this, it is of great
importance to investigate the effects of various food-relevant CER concentrations on the models of
intestinal epithelium. To mimic the contact of CER in food with the human digestive tract in the
current study the Caco-2 cell line (human colorectal adenocarcinoma) was selected as model for the
intestinal epithelial barrier. In addition, expected hepatoxic effects were assessed using HepG2 cells as
a model for human hepatocytes. Considering known mitochondrial toxicity of CER, the mitochondrial
respiration of Caco-2 and HepG2 was characterized as an indicator of cellular metabolism and
fitness in the function of the CER exposure by extracellular flux analysis of oxygen consumption rate
(OCR). Measurements of OCR deciphered key parameters of mitochondrial respiration when different
aspects of the electron transport chain were shut down. Through the use of mitochondrial inhibitors,
six mitochondrial respiration parameters can be determined: basal, ATP production-linked, maximal,
proton leak-linked OCR, spare respiratory capacity and non-mitochondrial respiration [32,33]. For this
purpose, the Agilent Seahorse XF24 technology was used to evaluate mitochondrial dysfunction in the
absence of cell death caused by (long-term) exposure of Caco-2 and HepG2 cells to low sub-emetic
concentrations of CER.
2. Results
2.1. Determination of Subacute Concentrations of CER on Caco-2 and HepG2 Cells
In preliminary experiments, the sub-acute concentrations were determined by exposing Caco-2
cells to a range of CER concentrations for 24 h and 72 h. After 1 day, the results of the MTT assay
indicated a significant decrease (p < 0.05) in cell viability, with a decrease of more than 50% starting at a
concentration of 1 nM CER. A similar, visually less pronounced decrease was observed in the SRB assay
(Figure 1A). Hence, higher concentrations, which already gave a significant decrease in cell viability
after 1 day, were omitted for the 3-day exposure (Figure 1B). According to the MTT assay, three days of
CER treatment significantly decreased Caco-2 cell viability with 21% and 43% compared to the untreated
cells after exposure to 0.25 and 0.50 nM CER, respectively (Figure 1B). CER induced significant reduction
(p < 0.05) in protein content in the SRB assay at≥0.25 nM (Figure 1B). The selected treatments (0.05–0.50
nM) induced toxicity, but the majority of the cells survived the exposure. Based on these findings, the
same concentration range was used for the subsequent study of long-term, 10-day, exposure.
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Figure 1. MTT assay and SRB assays after 1 day (A) and 3 days (B) treatment with cereulide (CER) in
undifferentiated Caco-2 cells. The absorbance is expressed as a percentage of the control values (0 nM
CER). Data (n = 12, four technical replicates and three independent repetitions) are presented as mean
values with standard deviations.
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In parallel, similar experiments were performed on undifferentiated HepG2 cells. As shown in
Figure 2A, CER concentrations of 2 nM and 5 nM resulted in a decrease of 30% and 35% of cell viability
after 24 h measured by the MTT assay. The toxicity was more pronounced based on the SRB results,
with reductions of 44% for 2 nM and 52% for 5 nM (Figure 2A). However, at these concentrations cells
continued to grow, and thus the same concentrations were used for an exposure of 3 days. Clearly,
the three-day treatment significantly reduced the cell viability compared to the one-day treatment
(Figure 2B). At 1 nM of CER and higher, viability of HepG2 was severely compromised deceasing
to about 50% as indicated by the MTT assay. The decrease in SRB absorption measurement were
even more drastic with a reduction of about 75%, indicating the impact on both metabolic activity of
cytoplasmic enzymes and cells and total protein amount. At these concentrations (≥1 nM) present
cells continued to function, with CER induced cellular alternations. To ensure sufficient number of
living cells after 10 days of exposure, the maximum exposure concentration was reduced to 0.50 nM
CER for the subsequent experiments.
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Figure 2. MTT assay and SRB assay after 1 day (A) and 3 days (B) treatment with CER in
undifferentiated HepG2 cells. The absorbance is expressed as a percentage of the control values
(0 nM CER). Data (n = 12, four technical replicates and three independent repetitions) are presented as
mean values with standard deviations.
2.2. Long-Term Effects of Cereulide on Mitochondrial Respiration of Caco-2 and HepG2 Cells
The effects on the mitochondrial respiration after 10-day exposure with varying doses of CER
were determined using the Seahorse XF Cell Mito Stress Test kit. The basal respiration and respiration
after sequential injection of oligomycin, Carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone
(FCCP) and rotenone + antimycin A are depicted in Figure 3 for undifferentiated Caco-2 cells. These
results are accompanied with MTT and SRB profiles shown in Figure 4. The OCR profile for HepG2
cells, is depicted in Figure 5.
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Figure 3. Effects of 10-day cereulid reatments on mitochond ial espiration of Ca o-2 cells.
(A) Mitochondrial profile; (B) mitochondrial parameters; (C) aximal respiration. Data (n = 12,
four technical replicates and three indep dent repetitions) are expr ssed as mean ± SD. * indicated a
significant difference at p < 0.05.
As shown in Figure 3, the mitochondrial respiration of the undifferentiated Caco-2 cells was
compromised starting at 0.25 nM CER. The toxic effects of CER were reflected in a decreased
non-mitochondrial respiration, ATP-linked respiration and especially in maximal respiration. Maximal
respiratory capacity was estimated by an FCCP-stimulated respiration and observed decrease is a
strong indicator of potential mitochondrial dysfunction [34]. Treatments with 0.05 nM CER had
small effects on respiration, with the exception of a significant reduction in aximum respiration,
which could not be observed with MTT, and SRB assays (Figure 4A). Treatments with up to 0.10 nM
CER did not affect the basal respiration of the Caco-2 cells, but produced a significant reduction
(p < 0.05) in the maximum respiration and ATP turnover. Higher concentrations of CER (0.25 and
0.50 nM) decreased mitochondrial respiration of cells even at the basal state, and their metabolic
activity has been largely decreased so that no effects of modulators were observed. Note that the
MTT/SRB results did not indicate significant reduction after treatment with 0.10 nM CER and even for
higher concentrations only moderate toxicity was observed (Figure 4A).
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Figure 4. MTT assay and SRB assay at the end of the treatment (10 days) with CER in undifferentiated
Caco-2 cells (A) and HepG2 cells (B). The absorbance is expressed as a percentage of the control values
(0 nM CER). Data (n = 12, four technical replicates and three independent repetitions) are presented as
mean values with standard deviations.
Figure 5 depicts the OCR pattern of undifferentiated HepG2-cells exposed to CER (0.05–0.50 nM).
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Similar effects have been seen with a significant reduction (p < 0.05) of ATP-linked respiration
and maximal respiration starting at 0.05 nM CER. After exposure to 0.50 nM CER, all mitochondrial
functions of the cells were severely compromised, whereas in Caco-2 cells comparable effects started at
0.25 nM CER. Maximal respiration significantly decreased with 50% following 0.25 nM CER treatment,
while a 98% decrease was observed after 0.50 nM CER exposure compared with the control. In parallel,
the mitochondrial ATP production declined to 58% (0.05 nM CER), 34% (0.25 nM CER) and 6% (0.50 nM)
of that of the untreated group. The experiments conducted in both cell lines indicated that various
CER treatments caused perturbations in the mitochondrial respiration, although the effects were more
pronounced in HepG2 cells. In both cell lines, the maximal respiration decreased in a dose-dependent
manner (Figures 3 and 5).
The generation of ATP through oxidative phosphorylation is one of the predominant
physiological functions of mitochondria. Since CER acts on mitochondria by uncoupling of
oxidative phosphorylation, the results confirmed the expected decrease in ATP production with
increasing CER concentration. The uncoupling effect of cereulide on mitochondrial respiration was
previously reported to be similar to those of uncouplers 2,4-dinitrophenol (DNP), carbonylcyanide
m-chlorophenylhydrazone (CCCP), and valinomycin [35]. The same authors reported the minimum
cereulide concentration to detect uncoupled oxygen consumption was 50 ng·mL−1 measured by
oxygen reduction in the reaction medium with isolated rat mitochondria. In our study, both maximal
respiration and ATP-linked respiration proved to be sensitive parameters for determination of the
mitochondrial dysfunction especially when compared to MTT and SRB assays. As a consequence,
also cell spare respiratory capacity (SRC) was impaired indicating an affected ability of the exposed
cells to cope with sudden increased need for ATP. The mitochondrial SRC is regarded as an important
aspect of the mitochondrial function and is given by the difference between maximal and basal
cellular OCR. When cells are subjected to stress, energy demand increases, with more ATP required
to maintain cellular functions. A cell with a larger spare respiratory capacity can produce more
ATP and overcome more stress, which indicates that this is an estimative of the cell’s ability to cope
with large increases in ATP turnover. Consequently, CER exposure, which is negatively affecting
the mitochondrial function, possibly exerts negative effects on the ability of cells to cope with other
stresses. This is in agreement with expected impact of CER on mitochondria by depolarization of
the mitochondrial inner membrane and impairment of ATP synthesis [36] by facilitating the passage
of K+ ions [6,35]. The impact of CER on mitochondrial ATP synthase that also translocates protons
across the inner membrane has been best observed after the addition of oligomycin. The presence of
oligomycin during the estimation of maximal respiration is important to prevent the reverse activity of
ATP synthase with rapid intracellular ATP depletion, which may lead to cellular metabolic dysfunction
and death. Hence, recent data showed that the presence of oligomycin significantly underestimates
FCCP-induced maximal OCR and SRC [37]. Finally, the addition of a potent respiratory chain inhibitor,
such as antimycin A, allows the estimation of non-mitochondrial OCR. The mitochondrial respiratory
chain in the inner membrane is proton translocating; H+ are pumped out of the matrix space when
electrons are transported along the chain. The considerable impact of CER on the metabolic fate of
exposed cells is based on the fact that mitochondria carry out most cellular oxidations and produce
the bulk of the cell’s ATP. Large amounts of NADH (and FADH2) are produced by the oxidation
reactions. The energy available from combining oxygen with the reactive electrons carried by NADH
and FADH2 is harnessed by the electron-transport chain. This respiratory chain pumps H+ out of
the matrix to create a transmembrane electrochemical proton gradient. In turn, the transmembrane
gradient is used both to synthesize ATP and to drive the active transport of selected metabolites across
the mitochondrial inner membrane [38].
Additionally, the Seahorse XF mitochondrial stress test was confirmed by MTT and SRB assays
(Figure 4B). Hence, the reduction in cell viability was rather low compared to the findings of the
Seahorse XF OCR measurements. In both cell lines, cell viability started to decrease significantly at
0.25 nM CER with a small reduction around 25% and 20% for Caco-2 cells and HepG2-cells, respectively.
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Especially for the highest concentration (0.50 nM CER), the effects were more pronounced according
to maximal OCR. Exposure to 0.50 nM resulted in a critically compromised OCR profile, while,
based on the SRB assay, 56% and 50% of the Caco-2 and HepG2cells respectively were still viable.
The findings indicated that the MTT/SRB assays proved to be less sensitive to the certain cytotoxic
effects of CER. Or in other words partial inhibition of the OCR does not have measurable effect on
cell density in Caco-2 and HepG2 cells. Moreover, measurements of fluxes give more information
about the ability of mitochondria to make ATP than do measurements of membrane potential that is
diminished by cereulide [25,39]. For the experiments with intact cells as done in the current study,
the best assay is the equivalent measurement of cell respiratory control, which reports the rate of ATP
production, the proton leak rate, the coupling efficiency, the maximum respiratory rate, the respiratory
control ratio and the spare respiratory capacity. This information is important to establish whether
the mitochondria in a stressed cell still generate ATP or are damaged and maintain their membrane
potential by hydrolysing glycolytic ATP.
Other in vitro toxicity studies indicated that, at extremely low doses, CER was toxic towards
porcine fetal Langerhans islets and beta cells. Within 2 days, 1 ng·mL−1 of CER caused necrotic cell
death of the islet cells hampering their insulin content [40]. In whole mouse islets apoptotic cell death
was observed in 75% of the islets after 72 h exposure with 0.25 ng·mL−1 CER [25]. These results
indicated that beta cells are even more sensitive to CER exposure than HepG2 cells. Nonetheless,
similar to our study, very low doses of CER impaired the mitochondrial activity of the cells. In the case
of beta cells this leads to impaired insulin secretion and cell death which both play key roles in the
regulation of the diabetes [41].
The exposure to CER slowed down the cell growth starting from a concentration of 0.10 nM CER.
Standard examination of the microscopic pictures revealed vacuolization in cells at 0.10 nM CER and
higher. In parallel, the reduction in basal respiration observed using the Seahorse XF Technology
corresponded to the decrease in cell number. Exposure with 0.50 nM CER induced cytotoxicity as the
cells were reduced in number as well as in size. Hence, based on the results of MTT and SRB assays,
the remaining cells appeared to be alive and active. In contrast, at this concentration mitochondrial
respiration could barely be observed in the Seahorse XF Cell Mito Stress Test. This suggested that
the microscopic observations corresponded to the data found with Seahorse XF Cell Mito Stress Test.
At the end of the HepG2 treatment period with 0.50 nM CER, the cell morphology was severely
impaired. The number and size of cells was highly reduced and the remaining cells were barely
viable as indicated by the MTT and Seahorse experiments. The results revealed that HepG2 cells
were relatively more sensitive to the measured cytotoxic effects of CER compared to Caco-2 cells.
Considering the dilution of cereulide in human body after the ingestion, the amounts of CER reaching
target cells are not known at the moment. Future physiologically-based kinetic (PBK) models are to
give insight into dose-, species-, matrix-and interindividual human variation-dependent effects of
cereulide. It is however clear that cereulide at very low doses induces damages in diverse organs
and cells, and that doses used in this study complement previous studies. They also add value to
the hypothesis that cereulide can causes cell death at low doses, and cell dysfunction at even lower
doses, not only in here tested HepG2 and Caco-2 cells. The current findings further depict relevance of
these low doses in mitochondrial respiration impairment that can result cell dysfunction. Recently,
a decreased basal respiration was noted in beta cells following 24 h exposure to 0.25–0.5 ng·mL−1
CER [25,41]. Based on current findings we may assume that other aspects than basal respiration
may be even more influences by the observed mitochondrial damages. Other potential pathological
traits, in addition to the observed mitochondrial impairment, should be considered at these doses,
as well. Cereulide is most likely not specific in its channel forming in biological membranes and acting
upon cross cell-membrane gradients of potassium ions can impair different metabolic regulators in
diverse mammalian cells, for example, the cells of innate and acquired immunity or voltage-gated
potassium channel (hERG) heart muscle cells [36]. Testing different cells types and assessing potential
risks for functional impairments is among other factors supported by reported findings that show
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that CER was found in the heart, brain, muscle and fat tissue of the piglets fed with feed containing
CER [42]. While the exact ratios of external and internal doses are not yet clear, and the investigations
are also influenced by the sensitivity of analytical methods used, one still needs to test effects of
lowest detectable concentrations. The absolute values and even the ratios between different aspects
of mitochondrial respiration following the exposure to low doses of CER may vary depending on
the medium in which the respiration analysis are done, and this should be taken into account when
extrapolating current findings to other experimental conditions [43].
It is also important to note that current experiments used established cell cultures that only
partially mimic actual physiological situations in humans. In the case of well-established Caco-2 cells
it is known that they express a large number of enzymes and transporter proteins present in normal
human intestinal epithelium, but it is also known that the gene expression profiles of transformed
epithelial cell lines like Caco-2, HT29 and normal human intestinal epithelium differ from each other.
However, the differences are not only found between the cell lines and normal epithelium, but also
between different cells lines, such as Caco-2 and HT29 cell lines [44–47]. Normal intestinal epithelium is
made up of several different cell types, and differences in gene expression profiles are not only observed
in the mucosal epithelium along the whole gastrointestinal tract, but also along the crypt-villus axis [47].
Therefore, one should not directly extrapolate current or any other in vitro findings to in vivo systems.
Still, intestinal epithelial cell models such as the Caco-2 cell model hold many advantages due to
their simplicity and reproducibility allowing inter-laboratory comparison of results. Furthermore,
pursuing an effect toxin in a cell line model opens the possibility of studies of molecular mechanisms
which may be more difficult to address in vivo [48]. Also, for HepG2 cells, many positive sides and
some downsides can be noted in comparison to primary human hepatocytes, which are considered
as the gold standard model for cytotoxicity studies. However, the scarce availability of fresh human
liver samples, complicated isolation procedures, limited life span, inter-individual variability, as well
as significant costs pose a profound obstacle in the use of primary hepatocytes [49,50]. Therefore,
immortalized liver-derived cell lines were proposed as an alternative for their unlimited availability
and phenotypic stability. A first alternative is the widely used human hepatocellular carcinoma cell
line HepG2. These cells are highly differentiated and display many of the genotypic features of normal
liver cells. Even their main limitation that is linked to their low metabolic capacities compared with
primary hepatocytes [51] and which makes them appropriate for testing the toxicity of the parent
molecule but less suited for metabolite toxicity testing was not an obstacle in our study. The latter is
due to the hypothesis that CER due its chemical stability does not metabolize in the liver, which is
proven by analysis of different tissues and body fluids in patients suffering CER intoxication [5,52].
3. Conclusions
Mitochondrial damage has been proposed as the mechanism underlying the induced
hepatotoxicity and intestinal cell damage associated with CER intoxication. Our in vitro studies
have shown that both Caco-2 and HepG2 cells are highly susceptible for the toxic effect of very low
CER concentrations. The concentrations tested are lower than those found in foods on the market
or even those reported in body fluids of patients diagnosed with severe forms of CER intoxication,
such as gastric fluid (4 ng·mL−1), blood serum (4 ng·mL−1), and urine (8 ng·mL−1) and stool samples
(160–800 ng/g) [52]. A long-term exposure of 10 days with 0.25 nM CER seemed to be a critical
concentration in both cell lines. However, the effects were even more pronounced in HepG2 cells.
This might suggest that chronic low exposure of CER might exert damaging effects at liver cell level.
As indicated in this in vitro study, CER exerts harmful effects to liver and epithelial colon cells at very
low doses, which are not associated with visual symptoms such as vomiting. The literature indicated
that low doses of CER are found in foods with no food intoxication history, supporting the hypothesis
of possible hidden exposure [17].
The use of Seahorse XF extracellular flux analysis of mitochondrial respiration is a suitable
model for the identification of mitochondrial toxicity of CER. When no significant reduction in cell
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viability was observed based on MTT and SRB results, the Seahorse XF Technology was able to detect
a reduced maximal respiration, which suggested that toxic impact might be underestimated or go
unnoticed based on MTT/SRB alone. This also confirms the importance of the role of mitochondrial
dysfunction in the absence of cell death when studying low doses of toxins [53]. Moreover, the use of
respiration modulators in Seahorse XF analysis provided critical information about the key parameters
of mitochondrial functions, which could not be evident in the measurements of basal respiration
alone. Especially the maximal OCR appeared to be more sensitive to the presence of CER than other
currently used assays for CER detection such as in vitro boar semen bio-assay where the threshold
concentration provoking visible mitochondrial damage was 2–4 ng·mL−1 [18,19,54]. Taken together,
chronic or repeated exposure to low doses of CER that are too low to cause visible effects of emesis is a
potential threat for human health.
4. Materials and Methods
4.1. Materials and Reagents
Dulbecco’s modified Eagle’s medium (DMEM), GlutaMAX™, penicillin/streptomycin and
non-essential amino acids were purchased at Life Technologies (Merelbeke, Belgium), whereas foetal
bovine serum was from Greiner Bio-One (Vilvoorde, Belgium). Phosphate buffered saline (PBS)
without Ca2+, Mg2+, was obtained from Westburg (Leusden, The Netherlands) and trypsin-EDTA
0.05% from Thermo Fisher Scientific (Merelbeke, Belgium).
4.2. Cell Culture
Caco-2 (human colorectal adenocarcinoma) and HepG2 (human hepatocellular carcinoma)
cells were obtained from ATCC and cultivated in Dulbecco’s Modified Eagle’s Medium (DMEM)
containing GlutaMAX™, 4.5 g/L D-glucose and pyruvate supplemented with 10% fetal bovine serum,
1% non-essential amino acids and 1% penicillin/streptomycin. The passage number of the cells used
in this study was maintained between 12 and 25. Cells were grown in T25 (25 cm2) polystyrene cell
culture flasks in a humidified chamber with 5% CO2 at 37 ◦C and 95% air atmosphere at constant
humidity. The culture medium of the cells was changed every other day and cell morphology was
daily checked by visual inspection with phase-contrast microscopy (Leica DMIC, Leica Microsystem
GMbH, Wetzlar, Germany). Caco-2 and HepG2 cells with a degree of confluence of approximately 80%
were subcultured to maintain their undifferentiated character and therefore the rapid growth of the
cells. For this purpose cells were gently rinsed with PBS and subsequently detached from the flask
with trypsin-EDTA 0.05% and seeded in a new T25 flask (ratio 1:5).
4.3. Exposure of Cells to Cereulide
The 1 mg·mL−1 solution of CER (Chiralix, Nijmegen, The Netherlands) was diluted to working
solutions (ranging from 0.05 to 10 nM) in cell culture medium to obtain the ‘exposure’ medium.
Chosen concentrations are lower or correspond to previously published minimal doses of CER needed
for a measurable response in bioassays and concentrations found in foods placed on the market.
These concentrations are also lower than concentrations reported in body fluids of patients diagnosed
with severe form of CER intoxication, such as gastric fluid (4 ng·mL−1), blood serum (4 ng·mL−1),
and urine (8 ng·mL−1) and stool samples (160–800 ng/g) [52].
The cells were subjected to CER treatment at 80% confluence. The growth medium was replaced
by CER containing exposure medium. During the 10 days exposure period, cells were allowed to grow
to 80% confluence before splitting. First, the non-exposed cells were counted with a Bürker counting
chamber according to the Trypan blue staining method and the number of cells·mL−1 of non-exposed
cells was obtained. Afterwards, the cells exposed to different CER concentrations were counted and
seeded at a cell density equal to that of the non-exposed cells. In this way, after each splitting, cells were
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seeded equally to obtain the same number of cells for each condition which allowed comparison of the
different concentrations.
4.4. Cell Viability and Protein Content Assays
Two widely established assays, MTT ((3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium
bromide) and SRB (sulforhodamine B), were used for characterization of the cell viability and cellular
protein content after Caco-2 and HepG2 cells were exposed to CER [55,56]. Caco-2 and HepG2 were
seeded to each well of the 96-well plates at a density of respectively, 20,000 cells and 30,000 cells
per well. Subsequently, the cells continued to grow in exposure medium for 24 h at 37 ◦C in an
incubator with a humidified atmosphere of 5% CO2. Mitochondrial activity of the exposed cells
was measured after 24 h with the MTT assay. Briefly, 20 µL of MTT dissolved in PBS at 5 mg·mL−1
was added to all wells of the assay, and plates were incubated at 37 ◦C for 2 h to convert MTT to
formazan. After incubation, medium was discarded and the purple formazan crystals were solubilized
in dimethylsulfoxide (DMSO). Absorbance was recorded at the wavelength of 570 nm by SpectraMax
M2 multimode plate reader (Molecular Devices, Sunnyvale, CA, USA). In parallel, the SRB assay was
used for cellular protein content measurement. The cell monolayers were fixed with 50 µL of 50%
trichloroacetate (TCA) in milliQ-water and stained for 1 h. After washing, cells were stained with
50 µL of SRB solution (0.4% in 1% glacial acetic acid). After 30 min, the plate was rinsed with 1% glacial
acetic acid in MilliQ®-water and dried for 30 min. The excess was removed by washing repeatedly
with 1% glacial acetic acid and the protein-bound dye was dissolved in 10 mM Tris buffer. Absorbance
was determined at 490 nm with SpectraMax M2 multimode plate reader. For each cell line and CER
concentration, twelve repeats of different cell preparations were made. Both assays were used for the
preliminary determination of the sub-emetic concentrations after 1 and 3 days, and as additional tests
after a prolonged exposure of 10 days with low doses of CER.
4.5. Seahorse Extracellular Flux Analysis of Mitochondrial Respiration
Mitochondrial respiration in Caco-2 and HepG2 cells was characterized as an indicator of cellular
metabolism and fitness in response to the exposure to CER by extracellular flux analysis using Agilent
Seahorse XF24 Analyzer (Agilent Seahorse Bioscience, Santa Clara, CA, USA). For this purpose, Agilent
Seahorse XF Cell Mito Stress Test was applied to both undifferentiated Caco-2 cells and HepG2 and
oxygen consumption rate (OCR) was measured in function of time and added respiration modulators.
In short, one day prior to the assay, cells were harvested from the T25 plates in which the cells were
exposed to CER. The cells were seeded at 40,000 cells per well (optimized cells density is crucial in the
assay [57]) in a Seahorse 24-well XF Cell Culture microplate in 250 µL of the exposure medium and
were allowed to adhere for 24 h in a 37 ◦C humidified incubator with 5% CO2. In addition, the Seahorse
XF Sensor Cartridge was hydrated the day before running the XF Assay by filling each well of the
XF Utility Plate with 1 mL of Seahorse XF Calibrant Solution. The hydrated cartridge was kept in
a non-CO2 37 ◦C incubator for 24 h to remove CO2 from the media that would otherwise interfere
with measurements that are pH sensitive. On the day of analysis, unbuffered XF Assay Media was
used for extracellular flux measurements. For this reason, the cells were washed three times with
non-buffered DMEM supplemented with 10 mM glucose, 2 mM sodium pyruvate and 2 mM glutamine
(adjusted to pH 7.4) and then maintained in 450 µL·well−1 of XF assay media at 37 ◦C in a non-CO2
incubator for 1 h to allow pre-equilibrate with the XF Assay Medium. Mitochondrial function of
the cells was analyzed by sequential injections of modulators (with shown final concentration in the
wells): oligomycin (1 µM) was used to block ATP synthase, carbonyl-cyanide-4-(trifluoromethoxy)
phenyhydrazone (FCCP, 0.25 µM) was used to make the inner mitochondrial membrane permeable for
protons and allow maximum electron flux through the electron transport chain, and a mix of rotenone
(0.5 µM) and antimycin A (0.5 µM) were used together to inhibit complexes I and III, respectively.
These compounds were suspended in pre-warmed XF Assay Medium and loaded into the designated
injection ports of the hydrated sensor cartridge corresponding to the order of injection.
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Subsequently, the loaded XF Sensor Cartridge with the XF Utility Plate was placed into the
XF24 Analyzer and calibrated. After calibration, the XF Utility Plate with the calibration fluid was
replaced with the plate containing cells. Each measurement cycle consisted of 3 min of mixing,
2 min of waiting, and 3 min of OCR measurements. First, three basal OCR measurements were
performed before the addition of modulators, followed by the sequential addition of oligomycin,
FCCP, and rotenone/antimycin A. Measurement cycles were performed after each addition of given
compounds. Through use of mitochondrial inhibitors six mitochondrial respiration parameters were
determined: basal, ATP production-linked, maximal, proton leak-linked OCR, spare respiratory
capacity and non-mitochondrial respiration.
4.6. Data Analysis
Statistical analyses were performed using the GraphPad Prism V6.01 software package (GraphPad
Software, Inc., San Diego, CA, USA). Comparisons between the control and CER treatments were
done by performing one-way analysis of variance (ANOVA) tests followed by post hoc analysis with
Dunnett’s multiple-comparison test. Differences were considered significant at p < 0.05. Data are
presented as mean ± SD.
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